OnX Liver Assessment Solution
In Clinic Diagnosis with Ultrasound and AI
JANUARY, 2023
Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Oncoustics is unique and does not do image recognition alone. Instead, we apply AI to raw ultrasound signals from readily available handheld ultrasound devices to rapidly differentiate healthy versus diseased tissues. Initially we are targeting liver disease, a $30B global diagnostic market.
- Rapid 5-10 min PoC exam
- Hardware-agnostic solution for any US device
- Unique use of additional data stream for AI/ML biomarkers
- Designed for non-experts with acquisition guidance
- Exclusive data libraries acquired with a custom protocol
- Automated analysis and enhanced visualization/ disease maps
Disease Detection in 5 Minutes
Executive Team
Beth Rogozinski, CEO -
Serial entrepreneur in tech and med. CEO, Signal 2 Health, CPO, Pear Therapeutics. Produced >30 apps and > 12 for healthcare w/ 2 FDA approvals
Dr. Ahmed El Kaffas, Founder -
Founder Faculty at Stanford University. 12+ years in US, image/signal processing, algorithm development and cancer tissue characterization
Dr. Sam Lee, Chief Medical Advisor -
Professor of Hepatology, University of Calgary Renowned Hepatologist. He has published >180 scientific papers and >20 book chapters.